Skip to main content
Official Website of Stem Cell Mexico – Since 2002
Stem Cell Therapy Mexico

How effective is Stem Cell Therapy for Joint Pain?

Stem cell therapy is effective for many patients with joint pain, particularly those with mild to moderate osteoarthritis of the knee, where the evidence is strongest.

Free Consultation
Joints location on a neutral human figure

A 2024 systematic review and meta-analysis of randomized controlled trials found that mesenchymal stem cell (MSC) injections reduced pain more than hyaluronic acid at 12 months and improved function on WOMAC scores, with no difference in serious adverse events compared with control treatments. A randomized trial specifically using umbilical cord MSCs found significantly better pain and function scores at 12 months than hyaluronic acid. For other joints and tendons, clinical studies report improvements in pain and function in many patients. At Stem Cell Mexico, joint protocols use only allogeneic MSCs from Wharton's jelly of the umbilical cord, applied with ultrasound guidance and often combined with platelet-rich plasma (PRP). Effectiveness depends on the joint, the stage of degeneration, body weight and rehabilitation, and results vary from patient to patient.

This guide explains how effectiveness is measured, what the trials found, how long results tend to last and what you can do to get the most from treatment.

How effectiveness is measured

Joint pain is personal, so doctors and researchers use standardized tools to measure change:

  • Pain scales: the Visual Analogue Scale (VAS) or Numeric Rating Scale (NRS), from 0 (no pain) to 10 or 100 (worst pain).
  • WOMAC index: a questionnaire for hip and knee osteoarthritis that scores pain, stiffness and physical function.
  • KOOS and similar scores: measure symptoms, daily activities, sports and quality of life for the knee; equivalent scores exist for the shoulder, hip and ankle.
  • Functional tests: walking distance, time to climb stairs, rising from a chair.
  • Medication use: whether patients can reduce painkillers or anti-inflammatory drugs.
  • Imaging: MRI changes in cartilage or inflammation, which do not always match symptoms.

For an individual patient, the most useful measures are personal goals: walking without pain, sleeping through the night, returning to golf or tennis, or managing stairs at home.

What the trials found

Knee osteoarthritis: the strongest evidence

  • Meta-analysis, Journal of Orthopaedic Translation, 2024: analyzed randomized controlled trials of MSC therapy for knee osteoarthritis. MSC injections reduced pain more than hyaluronic acid at 12 months and improved function on WOMAC scores. Serious adverse events were similar to those in control groups.
  • Umbilical cord MSCs, Stem Cells Translational Medicine: a randomized controlled phase I/II trial compared umbilical cord MSCs with hyaluronic acid. Patients who received repeated cord MSC injections had significantly better pain and function scores at 12 months, with no serious adverse events attributed to the cells.

Other joints and tendons

Clinical studies of cell-based treatments for the hip, shoulder, ankle, elbow and tendons report improvements in pain and function in many patients. The 2020 NBA Orthobiologics Consensus Statement, written by sports medicine experts who care for professional athletes, recognized the growing role of cell-based and other biologic treatments and recommended careful patient selection and image-guided application, which are part of our protocols.

Safety

Across randomized trials in knee osteoarthritis, MSC injections have shown a favorable safety profile, with temporary pain, swelling or stiffness as the most common effects.

What patients commonly report

When treatment works well, patients usually describe practical changes rather than a dramatic transformation:

  • Less pain when walking, climbing stairs or getting up from a chair.
  • Less morning stiffness and faster warm-up before activity.
  • Better sleep because of less night pain.
  • Fewer painkillers or anti-inflammatory tablets.
  • More confidence to exercise, travel or return to a sport.

Some patients notice improvement in one area, such as pain at rest, before others, such as pain during sport. Others improve more modestly. Comparing your scores and goals before and after treatment is the clearest way to see your own result.

How long results last

In published trials, follow-up commonly extends to one or two years, and many patients maintain improvement throughout that period. Some patients maintain benefit longer; others benefit from a PRP session or a second cell application after a year or more. Durability depends on the stage of osteoarthritis, body weight, activity level and whether the joint continues to be overloaded.

A typical timeline

  • First days: temporary soreness, swelling or stiffness in the treated joint is common and does not predict the final result.
  • Weeks 1 to 4: based on what patients tell us, many begin to notice less pain and stiffness during this period.
  • Months 1 to 6: gradual improvement as rehabilitation progresses; trials commonly report meaningful changes at 6 and 12 months.
  • Months 6 to 12: the period when most trials measure their main results.

Because improvement is gradual, judging results in the first two weeks is not reliable. A short diary of pain, sleep and activity during the first months helps you and the doctor see the trend.

Factors that influence effectiveness

  • Stage of osteoarthritis: results tend to be better in early to moderate disease (Kellgren-Lawrence grades 2 to 3) than in advanced grade 4, when cartilage is largely lost.
  • The joint involved: the knee has the most evidence; the hip and shoulder require precise guidance; small joints of the hand and foot are treated with smaller volumes.
  • Body weight: each extra kilogram increases load on the knees and hips; weight management improves results.
  • Alignment and stability: a joint that is unstable or badly misaligned may continue to wear despite treatment.
  • Rehabilitation: strength and mobility work after treatment are part of what makes results last.
  • Recent steroid injections: corticosteroids can affect cells, so the doctor reviews the timing of any recent cortisone injection.
  • General health: smoking, diabetes and inflammatory conditions influence healing.

How it compares with other injections

TreatmentWhat it doesTypical duration of relief
CorticosteroidSuppresses inflammation quicklyWeeks to a few months
Hyaluronic acidAdds lubricationVariable, often a few months
PRPDelivers your own growth factorsSeveral months to about a year
MSCs (with or without PRP)Anti-inflammatory and trophic signalingTrials commonly follow patients for one to two years

The NICE guideline on osteoarthritis (NG226) places exercise, weight management and education at the center of care, and regenerative treatment works best when it supports, rather than replaces, these measures.

What our patients usually receive

Based on the treatment plans our team prepares for patients, a typical joint protocol at Stem Cell Mexico includes:

  • 20 to 40 million Wharton's jelly MSCs per joint, applied by direct injection with ultrasound guidance.
  • Platelet-rich plasma (PRP) in many plans, applied together with the cells.
  • One night at our facilities with nursing and medical monitoring.
  • Consultation with your doctor and the stem cell specialist, pre-treatment laboratory tests and ground transportation from the San Diego airport area.
  • Your recent imaging: an MRI of the area no older than three months is requested.

One joint typically costs $3,900 to $6,000 USD, two or more joints $6,000 to $9,000 USD, and a joint-specific osteoarthritis plan $6,000 to $8,000 USD. Our team stays in contact after treatment to follow your progress and decide whether a second application or a PRP session could help.

How to get the most from treatment

  1. Bring recent imaging so the doctor can stage your joint accurately.
  2. Set two or three specific goals before treatment and write them down.
  3. Follow the activity plan: relative rest for a few days, then progressive loading.
  4. Work with a physical therapist on strength, mobility and balance.
  5. Manage weight and stay active with low-impact exercise such as cycling, swimming or walking.
  6. Record pain and function at one, three, six and twelve months.

Who may be a candidate

  • Mild to moderate osteoarthritis, chronic tendinopathy or partial tears confirmed by imaging.
  • Pain that has not improved enough with exercise, physical therapy and medications.
  • No active infection in the joint and no cancer within the past five years.
  • Willingness to follow rehabilitation after treatment.

Questions to ask during your evaluation

  • What stage is my joint, and what results are realistic for that stage?
  • How many cells are recommended, and will PRP be included?
  • How will we measure progress, and when?
  • How long should I wait after a recent cortisone injection?
  • What should my rehabilitation look like?

Bottom line

Stem cell therapy is effective for many patients with joint pain, with the strongest evidence in knee osteoarthritis, where randomized trials show greater pain relief and better function than hyaluronic acid at 12 months and a favorable safety profile. At Stem Cell Mexico, Wharton's jelly MSCs are applied with ultrasound guidance, often with PRP, as part of a plan that includes exercise and follow-up, and results vary from patient to patient. A medical evaluation can help determine whether this type of regenerative treatment is appropriate for your joints, goals and medical history.

References

  1. Tabet CG et al. Advanced therapy with mesenchymal stromal cells for knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. Journal of Orthopaedic Translation, 2024 (opens in a new tab)
  2. Matas J et al. Umbilical cord-derived mesenchymal stromal cells (MSCs) for knee osteoarthritis: repeated MSC dosing is superior to a single MSC dose and to hyaluronic acid in a controlled randomized phase I/II trial. Stem Cells Translational Medicine, 2019 (opens in a new tab)
  3. NICE guideline NG226: Osteoarthritis in over 16s, diagnosis and management (opens in a new tab)
  4. Cole BJ et al. The 2020 NBA Orthobiologics Consensus Statement. Orthopaedic Journal of Sports Medicine, 2021 (opens in a new tab)

Request your medical evaluation

A clearer path starts here.

Tell us a little about yourself. We’ll help you understand the next step.

Vania, patient coordinator at Stem Cell Mexico

Vania, our patient coordinator

Your questions. Your travel plans.
A real person to help.

Talk to Vania on WhatsApp (opens in a new tab)

What happens next?

  1. Your advisor contacts you.
  2. We explain the medical review.
  3. You explore your options.

Call +1 800 646 0290

Let’s begin with you.

Your inquiry starts a conversation. Treatment requires medical evaluation.

Vania · Patient Advisor

Start my free evaluation
Free Consultation